文献速递类风湿关节炎

类风湿关节炎患者侵袭性真菌感染:德国RABBIT登记探索性分析

Invasive fungal infections in patients with rheumatoid arthritis: an explorative analysis from the German RABBIT register.
PubMed 文献 · RMD Open · 2025-11-04

多变量时依Cox回归显示高龄、男性、吸烟史、心血管病、慢性肺病、其他自身免疫病及GC使用与IFI发生相关。

要点

  • RA患者IFI发生率0.65/1000患者年,病死率35%,病原以耶氏肺孢子菌(35%)和念珠菌(33%)为主。
  • IFI发生与高龄、男性、吸烟史、心血管病、慢性肺病、其他自身免疫病及GC使用相关。
  • 除GC使用外,靶向RA治疗对IFI风险的整体影响似乎不如多病共存重要。

核心结论

  • RA患者中IFI罕见但危及生命,尤其发生于因相关合并症或吸烟史而具有感染易感性的患者。
  • 除GC使用外,靶向RA治疗对IFI风险的整体影响似乎不如多病共存重要。

研究设计与样本

  • 共纳入22 535例RA患者,发生69例IFI,发生率0.65/1000患者年,病死率35%(n=24)。

主要发现

  • 病原体为耶氏肺孢子菌(35%)、念珠菌属(33%)和曲霉菌属(13%)。
  • IFI患者平均年龄65.4岁,54%为女性,80%有吸烟史,84%使用GC,91%住院时存在任何感染风险相关合并症。
  • IFI发生与高龄(每10年HR 1.36,95%CI 1.05至1.76)、男性(HR 1.92,95%CI 1.14至3.21)、吸烟史(HR 2.43,95%CI 1.35至4.37)、心血管病(HR 3.03,95%CI 1.80至5.10)、慢性肺病(HR 2.09,95%CI 1.21至3.61)、其他自身免疫病(HR 2.11,95%CI 1.10至4.07)及GC使用(HR 1.17,95%CI 1.11至1.22)相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To explore characteristics and treatment of patients with rheumatoid arthritis (RA) with invasive fungal infections (IFIs) and to describe infection details and outcome. METHODS: IFIs reported to the German RABBIT (Rheumatoid Arthritis: Observation of Biologic Therapy) register between May 2001 and December 2023 were analysed using a two-stage approach. First, a detailed case description, including a comparison of cases by infection outcome, was conducted using routine register data and hospital discharge letters. Second, a multivariable time-dependent Cox regression model was fitted to analyse associations with IFI development using routine register data only. RESULTS: Among 22 535 patients with RA, 69 IFIs occurred (incidence rate: 0.65/1000 patient-years), with a case fatality of 35% (n=24). Causative pathogens were Pneumocystis jirovecii (35%), Candida spp (33%) and Aspergillus spp (13%).Patients with IFIs were on average 65.4 years old; 54% were female, 80% ever-smokers, 84% glucocorticoid (GC) users and 91% had any infection-risk associated comorbidity at hospitalisation. IFI development was associated with older age (HR 1.36 per 10 years (95% CI 1.05 to 1.76)), male sex (HR 1.92 (95% CI 1.14 to 3.21)), ever-smoking (HR 2.43 (95% CI 1.35 to 4.37)), cardiovascular disease (HR 3.03 (95% CI 1.80 to 5.10)), chronic lung disease (HR 2.09 (95% CI 1.21 to 3.61)), other autoimmune disease (HR 2.11 (95% CI 1.10 to 4.07)), and the use of GCs (HR 1.17 (95% CI 1.11 to 1.22)). CONCLUSION: In patients with RA, IFIs are rare but life-threatening. They occur particularly in patients who are predisposed to infection due to relevant comorbidities, a history of smoking or both. Except for GC use, the overall impact of targeted RA treatment on the risk of IFI appears to be less relevant than that of multimorbidity.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Purschke A, Zietemann V, Herzer P, et al. Invasive fungal infections in patients with rheumatoid arthritis: an explorative analysis from the German RABBIT register. RMD Open. 2025. PMID: 41193231. doi:10.1136/rmdopen-2025-005961

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。